PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma. - Stewart J; Krastev DB; Brough R; Zatreanu D; Song F; Baxter JS; Sridhar S; Frankum J; Konde A; Yang W; Haider S; Alexander J; et al. (Oncogene, 2025)